Isolated limb perfusion in the management of in-transit melanoma metastases: A monoistitutional experience

被引：0
|
作者：
Patuzzo, R. [1 ]
Ruggeri, R. [1 ]
Gallino, G. [1 ]
Maurichi, A. [1 ]
Mattavelli, I. [1 ]
Baffa, G. [1 ]
Tinti, M. C. [1 ]
Castelli, G. P. [2 ]
Santinami, M. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Osped Siracusa, Siracusa, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3730
引用
收藏
页码：S865 / S865
页数：1
相关论文
共 50 条
  • [1] Management of in-transit melanoma of the extremity with isolated limb perfusion
    Fraker D.L.
    [J]. Current Treatment Options in Oncology, 2004, 5 (3) : 173 - 184
  • [2] Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases
    Deroose, Jan P.
    Grunhagen, Dirk J.
    Eggermont, Alexander M. M.
    Verhoef, Cornelis
    [J]. MELANOMA RESEARCH, 2015, 25 (05) : 427 - 431
  • [3] Isolated Limb Perfusion for In-Transit Melanoma Metastases: Melphalan or TNF-Melphalan Perfusion?
    Hoekstra, Harald J.
    Veerman, Kelly
    Van Ginkel, Robert J.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (04) : 338 - 347
  • [4] Isolated Limb Perfusion and Immunotherapy in the Treatment of In-Transit Melanoma Metastases: Is It a Real Synergy?
    Rastrelli, Marco
    Russano, Francesco
    Cavallin, Francesco
    Del Fiore, Paolo
    Pacilli, Claudia
    Di Prata, Claudia
    Rossi, Carlo Riccardo
    Vecchiato, Antonella
    Dall'Olmo, Luigi
    Mocellin, Simone
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (05):
  • [5] Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment
    Bhutta, Muhammad Eeman
    Siddique, Muhammad Hammad
    Siddique, Zainab
    [J]. EJSO, 2024, 50 (12):
  • [6] Effects of the Introduction of Modern Immunotherapy on the Outcome of Isolated Limb Perfusion for Melanoma In-Transit Metastases
    Carl-Jacob, Holmberg
    Mattsson, Jan
    Bagge, Roger Olofsson
    [J]. CANCERS, 2023, 15 (02)
  • [7] One hundred fifty six isolated limb perfusion (ILP) in melanoma patients with in-transit metastases
    Cavalcanti, A.
    Souadka, A.
    Israel, P.
    Mateus, C.
    Robert, C.
    Bonvalot, S.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 57 - 57
  • [8] 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
    Jan P. Deroose
    Alexander M. M. Eggermont
    Albertus N. van Geel
    Johannes H. W. de Wilt
    Jacobus W. A. Burger
    Cornelis Verhoef
    [J]. Annals of Surgical Oncology, 2012, 19 : 627 - 635
  • [9] 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
    Deroose, Jan P.
    Eggermont, Alexander M. M.
    van Geel, Albertus N.
    de Wilt, Johannes H. W.
    Burger, Jacobus W. A.
    Verhoef, Cornelis
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) : 627 - 635
  • [10] New Does Not Always Mean Better: Isolated Limb Perfusion Still Has a Role in the Management of In-Transit Melanoma Metastases
    Puzanov, Igor
    Skitzki, Joseph
    [J]. ONCOLOGY-NEW YORK, 2016, 30 (12): : 1053 - 1054
12345